AUA 2011 - Incidence of renal hemorrhage after extracorporeal shock wave lithotripsy in comparison with three shock wave generators in 482 hospitals; Japanese diagnosis procedure combination database - Session Highlights
AUA 2011 - Late breaking session: Prevention of BPH - Session Highlights
AUA 2011 - Long term complications in men after radical prostatectomy who have early or late radiation - Session Highlights
AUA 2011 - Obstetric complications of ureteroscopy during pregnancy - Session Highlights
AUA 2011 - Office based management of SUI in 2011 - Session Highlights
AUA 2011 - Panel discussion: Antimicrobial prophylaxis for genitourinary prosthetics - Session Highlights
WASHINGTON, DC USA (UroToday.com) - Lawrence Hakim noted that there are 30,000 GU prosthesis (IPP, AUS and slings) implanted each year.
AUA 2011 - Panel discussion: Recurrent UTIs in the female - Session Highlights
AUA 2011 - Postoperative pain after pure and robot-assisted laparoscopic radical prostatectomy. A prospective randomized study - Session Highlights
AUA 2011 - Previously developed systems-based biopsy model (Prostate Px+) identifies favorable-risk prostate cancer for men enrolled in an active surveillance program - Session Highlights
AUA 2011 - Renal and perirenal anatomy in the supine and prone position: implications for percutaneous stone treatment - Session Highlights
AUA 2011 - The development of patient specific simulator for laparoscopic renal surgery - Session Highlights
AUA 2011 - The management of polycystic kidneys in renal transplantation concomitant or staged nephrectomy - Session Highlights
AUA 2011 - Trends in surgical management of BPH - Session Highlights
AUA 2011 - Value of early confirmatory biopsies and centralized pathological review to select prostate cancer patients for active surveillance - Session Highlights
AUA 2011 - Whole genome microarray of the major pelvic ganglion after cavernous nerve injury: New insights into expression profiles after nerve injury - Session Highlights
AUA 2011 - Abiraterone acetate plus low-dose prednisone has a favorable safety profile, improves survival and produces PSA and radiographic responses in metastatic castration-resistant prostate cancer progressing after docetaxel-based chemotherapy: Result
WASHINGTON, DC USA (UroToday.com) - An update of COU-AA-301 by Dr. Fred Saad confirms the oncologic benefits and safety profile of Abiraterone acetate (AA) in patients with metastatic castration-resistant prostate cancer (mCRPC) post-docetaxel chemotherapy.
AUA 2011 - Regulatory role of miR-203 in prostate cancer progression and metastasis - Session Highlights
AUA 2011 - What is on the horizon in drug therapy for OAB? - Slide Presentation
AUA 2011 - New treatments present innovative approaches to painful bladder, chronic pelvic pain syndromes and interstitial cystitis - Press Release
WASHINGTON, DC USA (UroToday.com) - May 17, 2011 -
Drugs, devices show promise in providing relief for patients with debilitating bladder pain disorders